Skip to main content

Low-Oxygen Leaves a Lasting Mark on the Immune System

Hypoxia due to impaired lung function or high altitude led to epigenetic changes in the genome of neutrophils, cells important for fighting infection.

Written byRJ Mackenzie
| 2 min read
A mountain climber stands in front of snowy mountains and holds a blue canister of portable supplemental oxygen to his face to relieve symptoms of hypoxia due to the high altitude.
Register for free to listen to this article
Listen with Speechify
0:00
2:00

The human body hates not getting enough oxygen. Without it, confusion takes over, breathing and heart rate change, and skin turns blue. It turns out that the immune system feels the effects of not enough oxygen too. In a new study, researchers have shown that hypoxia also has long-term effects on successive generations of immune cells called neutrophils, which may impair the bodies’ ability to battle infection.1

Hypoxia Affects Neutrophils

Several serious medical conditions can result in hypoxia. Acute respiratory distress syndrome (ARDS) is a life-threatening illness that occurs when fluid leaks into the lungs. It can result from several conditions, including sepsis, trauma, or pneumonia. ARDS can lead to hypoxia as the lungs stop pumping oxygen around the body.

Research in mice had previously suggested that hypoxia could alter immune cells.2 Researchers at the University of Edinburgh, led by immunologist Sarah Walmsley, wanted to investigate whether the changes were mirrored in humans. They compared blood samples from 52 ARDS patients, both during their hospital stay and between three and six months later, with blood from healthy donors.

They found that ARDS survivors had impaired neutrophils, circulating first-line immune cells that battle infection. The patients were also more vulnerable to secondary bacterial infections.

Continue reading below...

Like this story? Sign up for FREE Immunology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

A closer look at the neutrophils from ARDS patients showed that, months after the disease, their cells lost an epigenetic mark called H3K4me3. Previous studies have shown that this modification is important for neutrophils’ antimicrobial activity.3

The researchers next turned their focus to other ways people can experience hypoxia, such as in high-altitude environments. They took blood samples from 20 healthy volunteers before and after they spent a week at 4,775m altitude near the mountain Huayna Potosí in Bolivia. The volunteers’ neutrophils showed proteomic changes that mirrored those that affected the ARDS patients’ cells and a similar loss of H3K4me3 in genes linked to immune function.

How the Epigenetic Changes Begin

The team wanted to explore how the changes to the cells' epigenetic markers began. To do so, they turned to mouse models of hypoxia. They found that the loss of H3K4me3 began in neutrophil progenitor cells in the mice’s bone marrow. In these cells, hypoxia induced a process called histone clipping, which cuts off part of the proteins that cells use to package DNA. This severance also reduced H3K4me3 levels.

The team wrote that the findings reveal more about how low-oxygen environments alter the immune system. They added that their research may provide helpful information for treating conditions in which neutrophil function contributes to pathology.

“Recognizing that low oxygen levels have a long-lasting effect on how early responder immune cells read their genetic code is important because it explains why these cells are less good at controlling infection many months after a severe respiratory illness. The [discovery] opens up new ways to think about treating long-term immune dysfunction and improve infection defenses,” said Manuel Alejandro Sanchez Garcia, a study coauthor and immunologist at the University of Edinburgh, in a press release.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • RJ Mackenzie

    RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years, where he also worked on the site’s SEO and editorial AI strategies. He created the site’s podcast, Opinionated Science, in 2020. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo